| abstract |
Provided is a method for preparing an 11-β-hydroxysteroid dehydrogenase type 1 enzyme inhibitor. A compound of formula (I) which is an 11-β-hydroxysteroid dehydrogenase type 1 enzyme inhibitor or a pharmaceutically acceptable salt, prodrug, prodrug salt or combination thereof, and non-insulin Methods can be provided for treating dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions mediated by excessive glucocorticoid action. [Selection figure] None |